Profile data is unavailable for this security.
About the company
Nova Organic Public Company Limited is a Thailand-based company, which is engaged in production and distribution of food supplements and health beverages. The Company also operates a contract manufacturing business. The Company’s brands include Donutt and Livnest. The Company's food supplement group offers products under the trademark Donutt, such as Donut Collagen and donuts total fibely. The Company's food supplement group offers products under other trademarks such as Ganoderma Plus Shitake Dietary Supplement, Matsutake Dietary Supplement Product and hair care products, Q-Tin, Hair Tonic, Serum and more. The Company's products include Cordyceps Coffee with Ganoderma Lucidum Extract, Cordyceps mixed with multivitamin B, Collagen Dipeptide Plus Calcium, Total Phybely, Collagen Peptides 4500, Gluta Plus, Moringa Coffee Livness Brand and Q-Tin hair serum.
- Revenue in THB (TTM)613.16m
- Net income in THB-67.80m
- Incorporated2021
- Employees295.00
- LocationNova Organic PCL190/4 Village No. 8 Naiklong, BangplakodSubdistrict Phra Samut, ChediSAMUT PRAKAN 10290ThailandTHA
- Websitehttps://www.novaonlinecenter.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDT Australia Limited | 251.87m | -159.15m | 820.49m | 156.00 | -- | 1.46 | -- | 3.26 | -0.022 | -0.022 | 0.035 | 0.0656 | 0.3741 | 2.39 | 3.51 | -- | -23.64 | -9.87 | -26.41 | -11.57 | 76.38 | 84.42 | -63.19 | -24.94 | 2.81 | -- | 0.0907 | -- | -42.03 | -11.97 | -632.59 | -- | -26.04 | -- |
| D.Western Therapeutics Institute Inc | 102.07m | -193.58m | 826.77m | 21.00 | -- | 2.71 | -- | 8.10 | -25.45 | -25.45 | 13.48 | 39.83 | 0.1607 | 0.4389 | 2.98 | 20,398,290.00 | -31.09 | -13.06 | -33.75 | -14.36 | 91.44 | 94.29 | -193.39 | -72.51 | 10.57 | -- | 0.4089 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
| Nova Organic PCL | 613.16m | -67.80m | 840.00m | 295.00 | -- | -- | -- | 1.37 | -0.117 | -0.117 | 1.04 | -- | 0.4251 | 3.59 | 15.13 | -- | -4.72 | 13.70 | -5.13 | 16.90 | 41.85 | 61.59 | -11.11 | 14.89 | 5.59 | -- | 0.0054 | -- | -13.76 | 13.37 | 19.45 | -- | 44.73 | -- |
| Kontafarma China Holdings Ltd | 3.81bn | -135.93m | 842.79m | 720.00 | -- | 0.1691 | 4.05 | 0.221 | -0.0052 | -0.0052 | 0.145 | 0.1892 | 0.4206 | 3.22 | 7.03 | 1,123,760.00 | -3.18 | -1.33 | -4.22 | -2.18 | 58.25 | 54.70 | -7.55 | -4.12 | 1.28 | -6.19 | 0.2392 | -- | -9.50 | -17.32 | 66.02 | -- | -- | -- |
| Canbridge Pharmaceuticals Inc | 525.85m | -1.94bn | 850.90m | 100.00 | -- | -- | -- | 1.62 | -0.9683 | -0.9683 | 0.2629 | -0.1017 | 0.1875 | 4.16 | 4.09 | 1,115,827.00 | -69.04 | -- | -154.20 | -- | 62.37 | -- | -368.26 | -- | 0.6132 | -41.34 | 1.39 | -- | 30.26 | -- | 21.64 | -- | -- | -- |
| Alpa Laboratories Limited | 507.01m | 78.95m | 853.45m | 318.00 | 10.76 | -- | 9.74 | 1.68 | 8.54 | 8.54 | 54.78 | -- | -- | -- | -- | 3,610,371.00 | -- | 5.39 | -- | 6.71 | 35.30 | 33.85 | 15.57 | 7.88 | -- | 109.23 | -- | -- | -17.20 | 8.14 | -10.71 | 34.99 | -10.58 | -- |
| Vaidya Sane Ayurved Laboratories Ltd | 461.65m | 16.03m | 865.20m | 632.00 | 53.92 | 3.58 | 29.41 | 1.87 | 3.46 | 3.46 | 99.55 | 52.12 | 1.74 | 11.90 | 20.17 | 1,654,093.00 | 6.04 | -- | 7.39 | -- | 71.79 | -- | 3.47 | -- | 2.57 | 16.25 | 0.0683 | -- | 32.55 | -- | 49.62 | -- | -- | -- |
| Kringle Pharma Inc | 16.82m | -206.30m | 875.32m | 13.00 | -- | 1.49 | -- | 52.05 | -158.59 | -158.59 | 12.88 | 374.93 | 0.024 | -- | 0.7308 | 5,428,846.00 | -29.38 | -19.00 | -30.70 | -20.23 | -- | -- | -1,226.76 | -156.51 | 26.45 | -1,190.33 | 0.00 | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| Bioalpha Holdings Bhd | 358.52m | -299.88m | 875.36m | -- | -- | 0.8569 | -- | 2.44 | -0.0275 | -0.0275 | 0.0338 | 0.0934 | 0.248 | 6.20 | 5.52 | -- | -21.57 | -12.76 | -24.65 | -13.77 | -0.5013 | 7.95 | -86.99 | -44.60 | 1.26 | -31.34 | 0.0949 | -- | 28.74 | -8.04 | 19.41 | -- | -39.39 | -- |
| SMS Lifesciences India Ltd | 1.31bn | 21.66m | 878.17m | 567.00 | 40.53 | -- | 12.39 | 0.6721 | 16.23 | 16.23 | 978.01 | -- | -- | -- | -- | 5,218,087.00 | -- | 5.33 | -- | 8.84 | 29.00 | 26.60 | 0.6645 | 4.99 | -- | 0.8533 | -- | 2.32 | -9.77 | 7.73 | -54.65 | 12.01 | 69.24 | -- |
